We are excited to invite you to our Annual General Meeting, taking place on Saturday, April 25th!

The Canadian Hemophilia Society (CHS) is reminding MyCBDR users to take part in the PROBE survey, a short, patient‑designed questionnaire that helps capture the real‑world experiences of people living with […]

A new study from Japan is shedding light on how often boys and young men with hemophilia can safely participate in sports, and why early adolescence may be a particularly […]

Researchers at the University of Rochester are interested in creating a patient-reported outcome measure that will assess the health, symptoms, and disease burden of individuals with von Willebrand disease. The […]

Hemophilia Ontario has submitted a formal letter to provincial health decision‑makers in alignment with the recent efforts of the Canadian Hemophilia Society, asking the province to accept the Canadian Blood […]

SickKids has been named the world’s best children’s hospital, topping Newsweek’s global ranking of 250 pediatric centres. The recognition reflects the hospital’s extensive specialized programs, groundbreaking research, and its role […]

BioMarin has announced that it is pulling Roctavian, its gene therapy for adults with severe hemophilia A, from the market. The company reported that demand for the therapy remained far […]

Give 2 hours. Make a local impact. Hemophilia Ontario is proud to be a licensed charity partner at Superior Shores Gaming Centre (435 Memorial Avenue, Thunder Bay) and we’re looking […]

The Ontario Ministry of Health has announced that the Ontario Hepatitis C Assistance Plan (OHCAP) will be winding down after nearly 30 years of providing equitable access to hepatitis C […]

The Canadian Hemophilia Society has announced an important evolution: a new national name—Bleeding Disorders Canada. This change reflects the growth and diversity of the bleeding disorders community and aims to […]